Curis updates on emavusertib trials in CLL and PCNSL, flags tight cash runwayNov 13Quarterly updateCuris, Inc.
FDA's zanubrutinib record expands with CLL/SLL approval detailNov 10Regulatory decisionBeiGenezanubrutinibUpdated
Genentech registers Phase I trial of RO7890597 in healthy volunteersSep 2Weekly roundup, 3 itemsBeiGeneobinutuzumab
BeOne Medicines files STAR Market interim report, discloses R&D spend by product under US GAAPAug 26Quarterly updateBeiGene
BeOne Medicines reports Q2 2026 results, raises full-year revenue guidanceAug 5Quarterly updateBeiGenesonrotoclax
AbbVie week: BOTOX oral pain results post; new CLL, myeloma, ABBV-859 trials filedJul 31Weekly roundup, 6 itemsABBV-859AbbVie